Toxoplasma and Toxocara seropositivity in juvenile idiopathic arthritis and its relation to disease activity and type of therapies

Ali, 2013, Clinical use of anti-TNF therapy and increased risk of infections, Drug, Healthc. Patient Safety., 5, 79, 10.2147/DHPS.S28801 Balleari, 1991, Adult-onset Still’s disease associated with Toxoplasma gondii infection, Clin. Rheumatol., 10, 326, 10.1007/BF02208701 Ćalasan, 2014, Interpretation of the juvenile arthritis disease activity score: responsiveness, clinically important differences, and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis, Rheumatol., 53, 307, 10.1093/rheumatology/ket310 Consolaro, 2009, Development and validation of a composite disease activity score for juvenile idiopathic arthritis, Arthritis Rheum., 61, 658, 10.1002/art.24516 Couper, 2008, IL-10: the master regulator of immunity to infection, J. Immunol., 180, 5771, 10.4049/jimmunol.180.9.5771 Cutolo, 2008, Use of glucocorticoids and risk of infections, Autoimmun. Rev., 8, 153, 10.1016/j.autrev.2008.07.010 Drozdova, 2017, Cytokine profile changes in children with juvenile idiopathic arthritis-associated uveitis, Vestn. oftalmol., 133, 27, 10.17116/oftalma2017133127-31 Dubey, 1998, Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts, Clin. Microbiol. Rev., 11, 267, 10.1128/CMR.11.2.267 El-Henawy, 2017, Anti-toxoplasma antibodies in Egyptian rheumatoid arthritis patients, Rheumatol. Int., 37, 785, 10.1007/s00296-017-3703-8 Ellerin, 2003, Infections and anti-tumor necrosis factor-alpha therapy, Arthritis Rheum., 48, 3013, 10.1002/art.11301 El-Sayed, 2016, The current status of Toxoplasma gondii infection among Egyptian rheumatoid arthritis patients, Asian Pac J Trop Med, 6, 797, 10.1016/S2222-1808(16)61133-7 Esfandiari, 2020, Seroprevalence of toxocariasis in multiple sclerosis and rheumatoid arthritis patients in Shiraz city, southern Iran, Clin. Epidemiol. Global Health., 8, 158, 10.1016/j.cegh.2019.06.005 Etewa, 2017, In vivo assessment of the effects of methotrexate on latent toxoplasmosis, J. Egypt. Soc. Parasitol., 47, 589 Fathy, 2017, Association of IL-10 gene polymorphisms and susceptibility to juvenile idiopathic arthritis in Egyptian children and adolescents: a case-control study, Ital. J. Pediatr., 43, 9, 10.1186/s13052-017-0328-1 Fischer, 2013, Toxoplasma gondii: bystander or cofactor in rheumatoid arthritis, Immunol. Res., 56, 287, 10.1007/s12026-013-8402-2 Gallardo, 2016, Toxocariasis and inflammatory joint disease, Gaceta de Ciencias Veterinarias., 21, 5 Hahn, 2021, Pathogenesis and clinical manifestations of juvenile rheumatoid arthritis, Korean J. Pediatr., 53, 921, 10.3345/kjp.2010.53.11.921 Hart, 1995, Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis, Immunology., 84, 536 Hezarjaribi, 2021, Toxoplasma gondii infection in patients with rheumatoid arthritis and systemic lupus erythematous diseases: serological and molecular evidence, Ann. Parasitol., 67, 223 Hill, 2002, Toxoplasma gondii: transmission, diagnosis, and prevention, Clin. Microbiol. Infect., 8, 634, 10.1046/j.1469-0691.2002.00485.x Hoes, 2007, EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases, Ann. Rheum. Dis., 66, 1560, 10.1136/ard.2007.072157 Hosseininejad, 2018, Toxoplasmosis seroprevalence in rheumatoid arthritis patients: a systematic review and meta-analysis, PLoS Negl. Trop. Dis., 12, 10.1371/journal.pntd.0006545 Hyrich, 2010, Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to pediatric rheumatology. Results from the childhood arthritis prospective study, Rheumatology (Oxford), 49, 116, 10.1093/rheumatology/kep352 Imperato, 2004, Long-term risks associated with biologic response modifiers used in rheumatic diseases, Curr. Opin. Rheumatol., 16, 199, 10.1097/00002281-200405000-00006 İnal, 2019, Toxoplasma gondii seroprevalence in rheumatoid arthritis patients treated with biological agents, J Surg Med., 15;3, 239 Jamal, 2021, The role of Toxoplasma gondii in trigger an autoimmune disease, IJRIAS., 6, 2454 Jimenez-Balderas, 2012, A study on parasites in Mexican rheumatic disease patients, J. Egypt. Soc. Parasitol., 42, 271, 10.12816/0006316 Jones, 2008, Toxoplasma gondii and Toxocara spp. co-infection, Am. J. Trop. Med. Hyg., 78, 35, 10.4269/ajtmh.2008.78.35 Kaplan, 2005, Toxocariasis seroprevalence in patients with rheumatoid arthritis, Turkiye Parazitol. Derg., 29, 251 Kuba, 2014, Detection of Toxoplasma antibodies and TNFα in rheumatoid arthritis patients treated with methotrexate, Iraqi J. Sci., 55, 1535 Lassoued, 2007, Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis, Semin. Arthritis Rheum., 36, 262, 10.1016/j.semarthrit.2006.08.004 Macpherson, 2013, The epidemiology and public health importance of toxocariasis: a zoonosis of global importance, Int. J. Parasitol., 43, 999, 10.1016/j.ijpara.2013.07.004 Magnaval, 2001, Highlights of human toxocariasis, Korean J Parasitol., 39, 1, 10.3347/kjp.2001.39.1.1 Moore, 2001, Interleukin-10 and the interleukin-10 receptor, Annu. Rev. Immunol., 19, 683, 10.1146/annurev.immunol.19.1.683 Nagy, 2019, The effects of TNF-alpha inhibitor therapy on the incidence of infection in JIA children: a meta-analysis, Pediatr. Rheumatol., 18;17, 4, 10.1186/s12969-019-0305-x Peng, 2021, The Association of Serum IL-10 levels with the disease activity in systemic-onset juvenile idiopathic arthritis patients, Mediat. Inflamm., 10.1155/2021/6650928 Petríková, 2010, Prevalence of toxoplasma antibodies among patients with various autoimmune diseases, Ann. Rheum. Dis., 69 Petty, 2004, International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton. J Rheumatol., 31, 390 Quéméneur, 2003, Differential control of cell cycle, proliferation, and survival of primary T lymphocytes by purine and pyrimidine nucleotides, J. Immunol., 170, 4986, 10.4049/jimmunol.170.10.4986 Rubinsky-Elefant, 2010, Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms, Ann. Trop. Med. Parasitol., 104, 3, 10.1179/136485910X12607012373957 Salman, 2015, Relationship between Toxoplasma gondii and arthritis among patients in Kirkuk city, Int. J. Curr. Res. Aca. Rev., 3, 175 Sumyuen, 1996, Effect of immunosuppressive drug regimens on acute and chronic murine toxoplasmosis, Parasitol. Res., 82, 681, 10.1007/s004360050185 Tian, 2014, Targeting IL-10 in auto-immune diseases, Cell Biochem. Biophys., 70, 37, 10.1007/s12013-014-9903-x Van Linthoudt, 1990, Arthritis of the hip- associated with infantile toxocariasis, Schweiz. Rundsch. Med. Prax., 79, 1022 Vass, 1977, Polytenosynovitis caused by Toxoplasma gondii, Bone Joint J., 59, 229 Williams, 1981, Arthritis and arthralgia associated with Toxocara infestation, Br. Med. J. Clin. Res., 283, 192, 10.1136/bmj.283.6285.192 Winthrop, 2015, Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance, Ann. Rheum. Dis., 74, 2107, 10.1136/annrheumdis-2015-207841